Introducción: los adultos mayores son considerados de riesgo por las disímiles vulnerabilidades que acompañan a la senescencia, de ahí que se recomienda la aplicación de procedimientos de la Medicina Natural y Tradicional para garantizar consigo una mayor calidad de vida. Objetivo: caracterizar el nivel de conocimiento y aplicación de la Medicina Natural y Tradicional en adultos mayores. Material y métodos: se realizó un estudio observacional, descriptivo de corte transversal en un grupo de adultos mayores pertenecientes al Policlínico Docente “Manuel González Díaz”, Bahía Honda, Artemisa; en el periodo de septiembre a octubre de 2020. El universo estuvo conformado por 150 adultos mayores, trabajándose con la totalidad. Se recogió la información a partir de una encuesta. Se utilizó estadística descriptiva. Resultados: predominó el grupo de edades de 60 a 69 años (35,33 %) y el sexo femenino (56,67 %). El 95,33 % (N=143) refirieron conocimientos sobre la Medicina Natural y Tradicional, consideraron los procedimientos terapéuticos como útiles y efectivos y afirmaron su aplicación. De ellos el 100 % refirió conocer y aplicar la fitoterapia como procedimiento terapéutico. Las recomendaciones de familiares y amigos fueron el medio de adquisición de los conocimientos sobre la Medicina Natural y Tradicional más representativo (76,92 %). Conclusiones: el nivel de conocimiento y aplicación de la Medicina Natural y Tradicional en los adultos mayores estudiados fue elevado. Es necesario aumentar en variedad la aplicación de procedimientos terapéuticos de la Medicina Natural y Tradicional y fomentar el papel de los profesionales de la salud como difusores de su utilidad.
Background/Objectives: HIV infection has been associated with an increased incidence of non-communicable comorbidities, including metabolic disorders. This phenomenon has been linked to gut microbiota dysbiosis, which involves not only changes in bacterial composition but also functional alterations in metabolite production. The objective of this study was to describe the impact of intestinal microbial metabolomics on the development of type 2 diabetes in people living with HIV. Methods: This study provides a narrative synthesis of current evidence addressing the role of gut microbiota-derived metabolites in immunometabolic regulation and their implications in HIV-associated type 2 diabetes. Results: Microbial metabolites play a fundamental role in regulating key physiological processes such as intestinal permeability, systemic immune activation, and glucose metabolism. Compounds such as short-chain fatty acids, tryptophan catabolites, secondary bile acids, trimethylamine N-oxide, and imidazole propionate have been shown to significantly influence immunometabolic balance. In people living with HIV, these microbial products may exert diverse effects depending on their chemical nature and the molecular pathways they activate in peripheral tissues. The interaction between dysbiosis, chronic low-grade inflammation, and HIV-associated metabolic disturbances may contribute to the early onset of type 2 diabetes beyond traditional risk factors. Conclusions: Recognizing the role of microbial metabolites in the context of HIV infection is essential to broaden our pathophysiological understanding of associated metabolic comorbidities. It also opens opportunities to develop more comprehensive diagnostic and therapeutic strategies that include modulation of the gut microbiota and its metabolic activity for the prevention and management of type 2 diabetes in this population.
People living with HIV (PLWHIV) have an increased risk of developing metabolic disorders, including type 2 diabetes (T2D), partly driven by chronic low-grade inflammation and immune dysregulation. This study evaluated the potential role of circulating miR-23a-3p as a possible early biomarker of prediabetes (preT2D) in PLWHIV. In this cross-sectional study, 80 adults were divided into five groups (n = 16 each): normoglycemic PLWHIV, PLWHIV with preT2D, PLWHIV with T2D, HIV-negative individuals with T2D, and controls. Clinical, anthropometric, biochemical, inflammatory, and insulin resistance (IR) markers were assessed, while plasma miR-23a-3p was quantified by digital PCR (dPCR). Bioinformatic network analysis was performed to identify potential molecular targets. PLWHIV with T2D showed the most unfavorable metabolic and inflammatory profile, including higher HbA1c, triglycerides, IL-6, TNF-α, hs-CRP, and GDF-15. In contrast, PLWHIV with preT2D exhibited significant overexpression of miR-23a-3p, whereas lower levels were observed in normoglycemic PLWHIV. miR-23a-3p correlated positively with IL-6 and GDF-15. ROC analyses showed good discriminative performance of miR-23a-3p for preT2D in PLWHIV (AUC = 0.80), and logistic regression confirmed its association with preT2D. In silico network analysis suggested potential inflammatory and metabolic targets of miR-23a-3p; however, these findings require experimental validation. These findings suggest that miR-23a-3p may represent a potential early biomarker of preT2D and immunometabolic dysfunction in PLWHIV.